GBT to Announce Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 24, 2021
February 17 2021 - 8:00AM
Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today
announced that it will report fourth quarter and full year 2020
financial results on Wednesday, February 24, 2021, after U.S.
financial markets close.
Management will host a conference call on
Wednesday, February 24, 2021, at 4:30 p.m. ET to provide a general
business update and to discuss fourth quarter and full year 2020
financial results. To participate in the conference call, please
dial 877-407-3982 (domestic) or 201-493-6780 (international). A
live audio webcast of the conference call can be accessed on GBT’s
website at www.gbt.com under the Investors section. An archived
audio webcast will be available for one month following the
event.
About Global Blood
TherapeuticsGlobal Blood Therapeutics (GBT) is a
biopharmaceutical company dedicated to the discovery, development,
and delivery of life-changing treatments that provide hope to
underserved patient communities. Founded in 2011, GBT is delivering
on its goal to transform the treatment and care of sickle cell
disease (SCD), a lifelong, devastating inherited blood disorder.
The company has introduced Oxbryta® (voxelotor), the first
FDA-approved treatment that directly inhibits sickle hemoglobin
polymerization, the root cause of red blood cell sickling in SCD.
GBT is also advancing its pipeline program in SCD with inclacumab,
a P-selectin inhibitor in development to address pain crises
associated with the disease, and GBT021601 (GBT601), the company’s
next generation hemoglobin S polymerization inhibitor. In addition,
GBT’s drug discovery teams are working on new targets to develop
the next generation of treatments for SCD. To learn more, please
visit www.gbt.com and follow the company on
Twitter @GBT_news.
Contact:Steven Immergut
(media)650.410.3258simmergut@gbt.com
Courtney Roberts
(investors)650.351.7881croberts@gbt.com
Global Blood Therapeutics (NASDAQ:GBT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Global Blood Therapeutics (NASDAQ:GBT)
Historical Stock Chart
From Apr 2023 to Apr 2024